
The $1.65B Non-Opioid Consolidation: How the NOPAIN Act and Viatris' Buyout Reshape Hospital Analgesic Economics
Dr. Dereck Mush, MD, MBAOperator of surgical facilities with an agreed HealthSpan Partners take-private transaction.
HealthSpan Partners agreed on October 26, 2026 to acquire Surgery Partners in a transaction with approximately $5.7 billion enterprise value. Eligible shareholders would receive $23.50 per share in cash; Bain affiliates will roll over shares. The transaction remains subject to shareholder and regulatory approvals. Enterprise value is not a venture funding round.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA